-

Shareholder Alert: Robbins LLP Informs Investors of Extended Class Period in Electric Last Mile Solutions, Inc. (ELMS, ELMSW) f/k/a Forum Merger III Corp. (FIII, FIIIU, FIIIW) Class Action

SAN DIEGO--(BUSINESS WIRE)--The Class: Shareholder rights law firm Robbins LLP informs investors that on April 4, 2022, a shareholder filed a class action on behalf of purchasers of Electric Last Mile Solutions, Inc. (NASDAQ: ELMS, ELMSW) f/k/a Forum Merger III Corp. (NASDAQ: FIII, FIIIU, FIIIW) securities for violations of the Securities Exchange Act of 1934. This filing effectively extended the class period to November 12, 2020 through February 1, 2022. ELMS is a commercial electric vehicle solutions company that designs, engineers, manufactures, and customizes electric delivery and utility vehicles.

If you suffered a loss due to Electric Last Mile Solutions, Inc.'s misconduct, click here.

What is this Case About: Insiders of Electric Last Mile Solutions, Inc. (ELMS) Bought ELMS Stock at a Substantial Discount and the Company's Financial Statements Cannot be Relied On

According to the complaint, Forum Merger III Corp., a special purpose acquisition company, and Electric Last Mile, Inc. completed their merger on June 25, 2021, with Electric Last Mile Solutions being the surviving publicly traded company. During the class period, defendants failed to disclose that ELMS' previously issued financial statements were false and unreliable and would have to be restated, and that certain ELMS executives and directors purchased equity in the Company at substantial discounts to market value without obtaining independent valuation.

On February 1, 2022, ELMS issued a press release announcing that its CEO and co-founder, and Chairman and co-founder, resigned from their positions. These departures followed an investigation conducted by a Special Committee of the Board of Directors, which had been formed in November 2021, following "an inquiry into certain sales of securities made by and to individuals associated with the company." These sales were purportedly at substantial discounts to market value without obtaining an independent valuation. The press release also stated that "the Board concluded that the Company's previously issued consolidated financial statements should be restated, and therefore, should not be relied upon." On this news, ELMS' shares declined over 50%.

Next Steps: If you purchased shares of Electric Last Mile Solutions, Inc. (ELMS, ELMSW) between November 12, 2020 and February 1, 2022, you have legal options. Contact us for more information.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Electric Last Mile Solutions, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:ELMS

Release Summary
Electric Last Mile Solutions, Inc.'s (ELMS) Financial Statements Cannot be Relied On
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Immutep Limited (IMMP) Misled Investors Regarding the Viability and Efficacy of its Drug CandidateOn May 5, 2026, a class action was filed on behalf of all investors who purchased or otherwise acquired Immutep Limited American Depository Receipts (NASDAQ: IMMP) between March 24, 2025 and March 12, 2026. Immutep is an Australian-based biotechnology company focused on developing Lymphocyte Activation Gene-3 (LAG-3) related i...
Back to Newsroom